Pirlimycin

Jump to navigation Jump to search

WikiDoc Resources for Pirlimycin

Articles

Most recent articles on Pirlimycin

Most cited articles on Pirlimycin

Review articles on Pirlimycin

Articles on Pirlimycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pirlimycin

Images of Pirlimycin

Photos of Pirlimycin

Podcasts & MP3s on Pirlimycin

Videos on Pirlimycin

Evidence Based Medicine

Cochrane Collaboration on Pirlimycin

Bandolier on Pirlimycin

TRIP on Pirlimycin

Clinical Trials

Ongoing Trials on Pirlimycin at Clinical Trials.gov

Trial results on Pirlimycin

Clinical Trials on Pirlimycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pirlimycin

NICE Guidance on Pirlimycin

NHS PRODIGY Guidance

FDA on Pirlimycin

CDC on Pirlimycin

Books

Books on Pirlimycin

News

Pirlimycin in the news

Be alerted to news on Pirlimycin

News trends on Pirlimycin

Commentary

Blogs on Pirlimycin

Definitions

Definitions of Pirlimycin

Patient Resources / Community

Patient resources on Pirlimycin

Discussion groups on Pirlimycin

Patient Handouts on Pirlimycin

Directions to Hospitals Treating Pirlimycin

Risk calculators and risk factors for Pirlimycin

Healthcare Provider Resources

Symptoms of Pirlimycin

Causes & Risk Factors for Pirlimycin

Diagnostic studies for Pirlimycin

Treatment of Pirlimycin

Continuing Medical Education (CME)

CME Programs on Pirlimycin

International

Pirlimycin en Espanol

Pirlimycin en Francais

Business

Pirlimycin in the Marketplace

Patents on Pirlimycin

Experimental / Informatics

List of terms related to Pirlimycin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Pirlimycin hydrochloride belongs to the lincosamide class of antimicrobials. It is bacteriostatic and acts by inhibiting bacterial protein synthesis via binding with the 50S subunit of the ribosome. It is frequently used in the treatment of bovine mastitis caused by Gram-positive bacteria, specifically Staphylococcus aureus and coagulase negative species of Staphylococcus and Streptococcus. It has no activity against Gram-negative bacteria.

Template:SIB Template:WH Template:WS